| 2023-08-04 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 4,057 0.0033% | $185.85 | $753,986 | -11.05% | |
| 2023-04-27 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 2,392 0.0019% | $194.59 | $465,464 | -8.05% | |
| 2023-02-10 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 38,044 0.0308% | $215.97 | $8.22M | -11.79% | |
| 2021-12-23 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President, R&D | 2,879 0.0024% | $190.93 | $549,698 | -16.26% | |
| 2021-08-09 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President, R&D | 10,834 0.0091% | $200.00 | $2.17M | -18.91% | |
| 2021-06-18 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President, R&D | 14,708 0.0124% | $175.00 | $2.57M | -3.94% | |
| 2021-04-21 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President, R&D | 2,732 0.0023% | $136.95 | $374,135 | +23.86% | |
| 2021-04-19 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President, R&D | 3,706 0.0032% | $137.67 | $510,192 | +23.97% | |
| 2020-09-29 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President, R&D | 971 0.0008% | $140.00 | $135,940 | +0.27% | |
| 2020-06-22 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President, R&D | 970 0.0008% | $151.07 | $146,536 | -8.51% | |
| 2020-04-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President, R&D | 21,971 0.0185% | $140.00 | $3.08M | -3.95% | |
| 2020-02-07 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President, R&D | 23,708 0.0209% | $125.00 | $2.96M | +7.8% | |
| 2018-03-14 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President, R&D | 177,108 0.1787% | $143.10 | $25.34M | -34.38% | |
| 2017-10-30 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, R&D | 67,332 0.0692% | $121.46 | $8.18M | -14.61% | |
| 2017-05-23 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, R&D | 22,000 0.0161% | $48.17 | $1.06M | +53.06% | |
| 2017-05-15 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | SVP, R&D | 43,750 0.0489% | $65.00 | $2.84M | +73.63% | |
| 2016-11-30 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, R&D, CMO | 58,330 0.0697% | $44.99 | $2.62M | +64.12% | |
| 2015-06-16 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, R&D, CMO | 17,500 0.0209% | $128.83 | $2.25M | -35.1% | |
| 2015-03-17 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, R&D, CMO | 17,500 0.0214% | $116.86 | $2.05M | -10.71% | |
| 2014-12-16 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | EVP, Chief Medical Officer | 21,252 0.0291% | $93.60 | $1.99M | +14.18% |